Evaluation of the results revealed pronounced clinical manifestations on the dorsal skin of DNCB-challenged mice, characterized by erythema, edema, scarring, dryness, excoriation, and hemorrhage (Fig. 2A), accompanied by elevated dermatitis scores and serum levels of IgE (Fig. 2B and C). This evidence concerns the gene IGHE and dermatitis.